InflaRx N.V. (IFRX)
NASDAQ: IFRX · Real-Time Price · USD
1.590
+0.030 (1.92%)
Oct 26, 2026, 11:35 AM EDT - Market open
InflaRx Market Cap
InflaRx has a market cap or net worth of $234.32 million as of October 26, 2026. It is the 19,806th most valuable company in the world and the 3,450th biggest in the United States. Its market cap has increased by 147.17% in one year.
Market Cap
234.32M
Enterprise Value
54.17M
1-Year Change
147.17%
Global Rank
Country Rank
#3,450 United States
Category
ChartMarket Cap Chart
Since November 8, 2017, InflaRx's market cap has decreased from $350.90M to $234.32M, a decrease of -33.22%. That is a compound annual growth rate of -4.40%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 26, 2026 | 234.32M | 242.57% |
| Dec 31, 2025 | 68.40M | -52.96% |
| Dec 31, 2024 | 145.40M | 51.46% |
| Dec 29, 2023 | 96.00M | -29.93% |
| Dec 30, 2022 | 137.00M | -34.85% |
| Dec 31, 2021 | 210.30M | 60.17% |
| Dec 31, 2020 | 131.30M | 27.72% |
| Dec 31, 2019 | 102.80M | -88.13% |
| Dec 31, 2018 | 866.00M | 76.55% |
| Dec 29, 2017 | 490.50M | 39.78% |
| Nov 8, 2017 | 350.90M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Vicore Pharma Holding AB | 245.38M |
| Larimar Therapeutics | 245.30M |
| Vanda Pharmaceuticals | 242.46M |
| Immuneering | 241.32M |
| AC Immune | 240.61M |
| Greenwich LifeSciences | 235.29M |
| Palisade Bio | 231.78M |
| Lyell Immunopharma | 230.10M |